Pradžia › Neuroblastoma › Masčusetsas › Boston

Neuroblastoma klinikiniai tyrimai Boston, MA

13 tyrimai dėl Neuroblastoma ieško dalyvių vietose Boston ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Renkami dalyviai3 fazė

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Iki 30 metų · Visoms lytims · Atnaujinta 2026-10-02 · NCT06172296

MCT for the Harvard/UCSF ROBIN Center

Renkami dalyviai

Brigham and Women's Hospital, Boston

Visi amžiai · Visoms lytims · Atnaujinta 2026-10-01 · NCT06000787

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Renkami dalyviai1/2 fazė

Dana-Farber Cancer Institute ( Site 1013), Boston

6 Months – 25 Years · Visoms lytims · Atnaujinta 2026-09-17 · NCT06395103

B7-H3.CD28Z.CART in Solid Tumors

Renkami dalyviai1 fazė

Dana Farber Cancer Institite, Boston

9 Months – 30 Years · Visoms lytims · Atnaujinta 2026-09-03 · NCT07358260

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Renkami dalyviai3 fazė

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

365 Days – 30 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Renkami dalyviai1/2 fazė

Dana-Farber Cancer Institute, Boston

12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT04851119

SPEARHEAD-3 Pediatric Study

Renkami dalyviai1/2 fazė

Dana Farber Cancer Institute, Boston

Amžius nuo 2 iki 21 · Visoms lytims · Atnaujinta 2026-08-11 · NCT05642455

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Renkami dalyviai1/2 fazė

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-07-22 · NCT06721689

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Renkami dalyviai2 fazė

Boston Children's Hospital, Dana-Farber Cancer Institute., Boston

Amžius nuo 1 iki 31 · Visoms lytims · Atnaujinta 2026-07-20 · NCT06450041

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

Renkami dalyviai1 fazė

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-07-14 · NCT07027748

Neuroblastoma Biology Study

Renkami dalyviaiStebimasis tyrimas

Children's Hospital Boston, Boston

31 Days – 99 Years · Visoms lytims · Atnaujinta 2026-03-23 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Renkami dalyviai

Dana-Farber Cancer Institute, Boston

Iki 17 metų · Visoms lytims · Atnaujinta 2026-02-10 · NCT06831552

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

Renkami dalyviai1/2 fazė

Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston

12 Months – 29 Years · Visoms lytims · Atnaujinta 2025-12-26 · NCT06803875

Neuroblastoma tyrimai kituose miestuose

Kiti tyrimai Boston

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.